News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
4718
Sources here
16
Companies here
38
Search results Stored financial headlines

Active search

4718 matching headlines

Ticker or company: HEALTHMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Cardinal Health CEO details M&A strategy and growth

Jason Hollar, Cardinal Health (CAH) CEO joins Yahoo Finance Executive Editor Brian Sozzi to detail how M&A strategy, specialty pharma growth, and drug volume dynamics are driving profits. Video Transcript 00:00 Speaker A Where do you want to take this business with acquisitions? 00:02 …

CAH main company C1AH34 main company CAH main company
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8% CAH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Luigi Mangione Pleads Guilty in US Case Over CEO Killing

Luigi Mangione pleaded guilty in a federal case over the fatal shooting of UnitedHealth Group executive Brian Thompson in December 2024. View Comments

UNH main company UNHH34 main company UNH main company UNH main company
Sharemaestro market context Trend signal active 52 weeks +19.8% UNH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bleichroeder (MDXH) reports 31.6M-share, 33.2% holding in MDxHealth

Bleichroeder LP and related parties have reported a 33.2% beneficial ownership in MDxHealth SA, totaling 31,648,563 Ordinary Shares. This significant stake was accumulated for investment purposes, including a recent purchase of over 24 million shares in a registered direct offering at $0.454 per share …

MDXH main company
Sharemaestro market context Price below Trend Line 52 weeks -75.4% · Next-week setup negative 39.0% MDXH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mangione Admits to Killing Healthcare CEO Brian Thompson

Luigi Mangione pleaded guilty to federal stalking charges related to the fatal shooting of UnitedHealth Group Inc. executive Brian Thompson. Mangione admitted on Friday in New York federal court that he shot and killed Thompson on Dec. 4, 2024. He faces life in prison. …

UNH main company UNHH34 main company UNH main company UNH main company UNH main company
Sharemaestro market context Trend signal active 52 weeks +19.8% UNH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OPKO Health (NASDAQ:OPK) Trading Down 5.4% - Here's What Happened

OPKO Health (NASDAQ:OPK) shares experienced a 5.4% drop in mid-day trading, closing at $1.325 with significantly lower trading volume than average. Despite the stock decline, the company recently reported better-than-expected quarterly earnings, with an adjusted loss of $0.01 per share against an anticipated $0.08 …

OPK main company
Sharemaestro market context Trend signal active 52 weeks -2.1% OPK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Molina Healthcare Inc. stock outperforms competitors on strong trading day

Molina Healthcare Inc. (MOH) stock rose by 3.27% to $212.43 on a generally down day for the market, outperforming both the S&P 500 and Dow Jones Industrial Average. The company's stock closed 13.25% below its 52-week high achieved in July.

MOH main company
Sharemaestro market context Trend signal active 52 weeks +21.8% MOH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Dividend Hike And Medicare Exit Strategy Altering The Investment Case For UnitedHealth Group (UNH)?

In August 2026, UnitedHealth Group's board authorized a cash dividend of US$2.32 per share, paid on September 22, 2026, to shareholders of record as of September 14, 2026, while also outlining further exits from certain Medicare Advantage plans and updated margin expectations. These moves, …

UNH main company UNH main company UNH main company
Sharemaestro market context Trend signal active 52 weeks +19.8% UNH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LifeStance Health Group (NASDAQ:LFST) Given New $13.00 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. has raised its price target for LifeStance Health Group (NASDAQ:LFST) to $13.00 from $9.00, while maintaining a "neutral" rating. This new target implies a potential upside of 2.48% from the stock's previous close. The company recently reported strong quarterly earnings, …

LFST main company
Sharemaestro market context Trend signal active 52 weeks +123.8% LFST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mangione Pleads Guilty in US Case Over Healthcare CEO Killing

Luigi Mangione pleaded guilty to federal stalking charges related to the fatal shooting of UnitedHealth Group Inc. executive Brian Thompson. He faces a maximum sentence of life in prison. This happened in New York federal court Friday morning. Mangione also faces charges in New …

UNH main company UNHH34 main company UNH main company UNH main company UNH main company
Sharemaestro market context Trend signal active 52 weeks +19.8% UNH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sensus Healthcare, Inc. Q2 2026: Revenue $2.29M, EPS $(0.53) — 10-Q Summary

Sensus Healthcare, Inc. (SRTS) reported a significant decline in its Q2 2026 financial results, with revenue falling to $2.29M and diluted EPS at $(0.53). This downturn was primarily attributed to fewer system sales, a shift towards Fair Deal Agreements and rental arrangements impacting revenue …

SRTS main company
Sharemaestro market context Price below Trend Line 52 weeks -12.0% SRTS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What is driving nursing shortages? It's 'not a supply problem'

Meghan Fitzgerald, Columbia Professor, Grey Ghost Capital Private Equity Investor and on the board of Tenet Healthcare joins Yahoo Finance's Julie Hyman to explain why the U.S. healthcare crisis stems from nurse retention and burnout rather than a labor supply shortage. Video Transcript 00:00 …

THC main company
Sharemaestro market context Trend signal active 52 weeks +49.2% · Next-week setup positive 56.2% THC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Reasons to Hold Hinge Health Stock in Your Portfolio for Now

Hinge Health HNGE is well-positioned for sustained growth, driven by robust revenue growth, expanding opportunities in Migraine and gastrointestinal (GI) care and a scalable AI-powered MSK platform. The raised 2026 outlook, broader enterprise reach and growing sales pipeline further support the growth outlook. However, …

HNGE main company
Sharemaestro market context Trend signal active 52 weeks +53.7% · Next-week setup positive 75.2% HNGE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Elevance Health (ELV). Shares have added about 6.8% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leading up to its …

ELV main company E1LV34 main company ELV main company A58 main company ELV main company
Sharemaestro market context Trend signal active 52 weeks +10.5% · Next-week setup negative 25.9% ELV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Should You Continue to Hold ACHC Stock at an 18.17X P/E Valuation?

Acadia Healthcare Company, Inc.ACHC benefits from strong long-term demand for behavioral health services. The company is expanding its network through joint ventures, de novo facilities and bed additions. Shares of ACHC have surged 113.1% year to date, significantly outperforming the industry's 13.2% growth during …

BTSG main company ACHC main company
Sharemaestro market context Trend signal active 52 weeks +148.1% · Next-week setup positive 64.7% BTSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health (NUTX) reported a significant increase in net income and adjusted EBITDA for Q2 2026, primarily due to reduced contract services costs and stock-based compensation, despite a decrease in total revenue. The company is actively expanding its hospital network with new facilities planned …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?

Hims & Hers Health, Inc. (NYSE:HIMS) shares fell over 6% in extended trading on August 10 after the telehealth company delivered another quarter of rapid growth alongside sharply weaker profitability. Revenue rose 38% year over year to $753.2 million, subscribers increased 19% to 2.89 …

HIMS main company HIMS main company
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1% HIMS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Elanco Investors Fail to Revive Sales Misrepresentation Suit

The Seventh Circuit Court of Appeals has ruled against Elanco Animal Health Inc. investors, preventing them from proceeding with claims that the company misrepresented its sales. The court upheld the dismissal of the proposed class action, stating that the investors did not adequately allege …

ELAN main company
Sharemaestro market context Price below Trend Line 52 weeks +32.2% ELAN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Solas Capital discloses 7.1% SANUWAVE Health (SNWV) position via managed funds

Solas Capital Management, LLC and its portfolio manager Frederick Tucker Golden have reported a 7.1% beneficial ownership stake in SANUWAVE Health, Inc. (SNWV) through managed funds. This ownership amounts to 610,968 shares, held by two private funds and one sub-advised fund, granting them shared …

SNWV main company
Sharemaestro market context Price below Trend Line 52 weeks -89.5% · Next-week setup negative 41.6% SNWV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms

Shares of Incannex Healthcare (IXHL) experienced their best day in five months, jumping over 19% on Wednesday, driven by expectations of regaining Nasdaq compliance and upcoming regulatory discussions for its sleep apnea drug. The company implemented a 1-for-30 reverse stock split to help meet …

IXHL main company
Sharemaestro market context Price below Trend Line 52 weeks -81.4% · Next-week setup negative 39.2% IXHL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Up Following Better-Than-Expected Earnings

Aveanna Healthcare (AVAH) shares gapped up after reporting better-than-expected earnings, with revenue rising 13.7% year over year to $670.5 million and adjusted EPS of $0.22, surpassing analyst estimates. The company also raised its 2026 guidance, projecting revenue above $2.68 billion and adjusted EBITDA above …

AVAH main company
Sharemaestro market context Trend signal active 52 weeks +64.9% AVAH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UnitedHealth Group Inc.: Target Price Consensus and Analysts Recommendations | UNH | US91324P1021

This article provides an overview of analyst recommendations and target price consensus for UnitedHealth Group Inc. (UNH). It details recent adjustments to price targets and ratings from various financial institutions like JPMorgan, Mizuho, and Morgan Stanley, largely maintaining or upgrading their outlooks. The consensus …

UNH main company
Sharemaestro market context Trend signal active 52 weeks +34.2% UNH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Armistice Capital (VSEE) reports 7.33% beneficial stake in VSee Health

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 7.33% in VSee Health, Inc., totaling 4,079,129 shares of common stock. The filing, a Schedule 13G/A, indicates shared voting and dispositive power over these shares, which are directly held by Armistice Capital …

VSEE main company
Sharemaestro market context Price below Trend Line 52 weeks -96.4% · Next-week setup negative 38.7% VSEE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

T. Rowe Price Associates (EHC) discloses 5.1% Encompass Health stake on Schedule 13G

T. Rowe Price Associates has filed a Schedule 13G, disclosing a 5.1% beneficial ownership stake in Encompass Health Corp (EHC), totaling 5,056,225 common stock shares. The filing indicates that T. Rowe Price Associates holds sole voting power over 4,897,333 shares and sole dispositive power …

EHC main company
Sharemaestro market context Trend signal active 52 weeks +1.1% · Next-week setup positive 55.9% EHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

T. Rowe Price discloses 4.9% Guardant Health (GH) holding in 13G/A

T. Rowe Price Associates, Inc. has filed a Schedule 13G/A, disclosing a 4.9% beneficial ownership in Guardant Health, Inc. (GH) as of June 30, 2026. The firm holds 6,514,828 shares, with sole voting power over 6,359,951 shares and sole dispositive power over all 6,514,828 …

GH main company
Sharemaestro market context Trend signal active 52 weeks +156.0% GH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sotera Health announces resignation of director James C. Neary

Sotera Health (NASDAQ:SHC) announced the resignation of James C. Neary from its Board of Directors, effective Thursday. The company clarified that his resignation was not due to any disagreements regarding its operations. This news follows Sotera Health's strong second-quarter financial results, where it surpassed …

SHC main company
Sharemaestro market context Trend signal active 52 weeks +15.0% SHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MDxHealth SA Stock 12‑Month Price Target Cut to $2.2, Implies 376% Upside

MDxHealth SA's average stock price target has been reduced from $2.8 to $2.2 by analysts, with individual forecasts ranging from $1 to $4. This updated target suggests a potential upside of approximately 376% from its recent closing price. The consensus rating for the stock …

MDXH main company
Sharemaestro market context Price below Trend Line 52 weeks -75.4% · Next-week setup negative 39.0% MDXH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context